0 false false false false false false false false false false true false false false false false false No description of principal activity 2022-11-01 Sage Accounts Production Advanced 2023 - FRS102_2023 613 190 85 275 338 423 xbrli:pure xbrli:shares iso4217:GBP 12294478 2022-11-01 2023-10-31 12294478 2023-10-31 12294478 2022-10-31 12294478 2021-11-01 2022-10-31 12294478 2022-10-31 12294478 2021-10-31 12294478 bus:Director1 2022-11-01 2023-10-31 12294478 core:WithinOneYear 2023-10-31 12294478 core:WithinOneYear 2022-10-31 12294478 core:RetainedEarningsAccumulatedLosses 2023-10-31 12294478 core:RetainedEarningsAccumulatedLosses 2022-10-31 12294478 bus:SmallEntities 2022-11-01 2023-10-31 12294478 bus:AuditExempt-NoAccountantsReport 2022-11-01 2023-10-31 12294478 bus:SmallCompaniesRegimeForAccounts 2022-11-01 2023-10-31 12294478 bus:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 12294478 bus:FullAccounts 2022-11-01 2023-10-31 12294478 core:FurnitureFittingsToolsEquipment 2022-11-01 2023-10-31 12294478 core:FurnitureFittingsToolsEquipment 2023-10-31 12294478 core:FurnitureFittingsToolsEquipment 2022-10-31
COMPANY REGISTRATION NUMBER: 12294478
JH SKIN CLINIC LIMITED
FILLETED UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 October 2023
JH SKIN CLINIC LIMITED
STATEMENT OF FINANCIAL POSITION
31 October 2023
2023
2022
Note
£
£
FIXED ASSETS
Tangible assets
4
338
423
CURRENT ASSETS
Stocks
750
700
Debtors
5
232
-----
-----
750
932
CREDITORS: amounts falling due within one year
6
2,334
3,017
--------
--------
NET CURRENT LIABILITIES
1,584
2,085
--------
--------
TOTAL ASSETS LESS CURRENT LIABILITIES
( 1,246)
( 1,662)
--------
--------
NET LIABILITIES
( 1,246)
( 1,662)
--------
--------
CAPITAL AND RESERVES
Profit and loss account
( 1,246)
( 1,662)
--------
--------
SHAREHOLDERS DEFICIT
( 1,246)
( 1,662)
--------
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
JH SKIN CLINIC LIMITED
STATEMENT OF FINANCIAL POSITION (continued)
31 October 2023
These financial statements were approved by the board of directors and authorised for issue on 15 April 2024 , and are signed on behalf of the board by:
JM Harrison
Director
Company registration number: 12294478
JH SKIN CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 31 OCTOBER 2023
1. GENERAL INFORMATION
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 20 Mannin Way, Lancaster Business Park, Caton Road, Lancaster, Lancashire, LA1 3SW.
2. STATEMENT OF COMPLIANCE
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. ACCOUNTING POLICIES
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Equipment
-
20% reducing balance
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
4. TANGIBLE ASSETS
Equipment
£
Cost
At 1 November 2022 and 31 October 2023
613
-----
Depreciation
At 1 November 2022
190
Charge for the year
85
-----
At 31 October 2023
275
-----
Carrying amount
At 31 October 2023
338
-----
At 31 October 2022
423
-----
5. DEBTORS
2023
2022
£
£
Corporation tax repayable
232
-----
-----
6. CREDITORS: amounts falling due within one year
2023
2022
£
£
Accruals and deferred income
408
390
Director loan accounts
1,926
2,627
--------
--------
2,334
3,017
--------
--------